Harnessing the Integrated Stress Response to Counteract Metabolic Disease
Anne S. Henkel – 13 July 2018
Anne S. Henkel – 13 July 2018
Juan Jovel, Zhen Lin, Sandra O'keefe, Steven Willows, Weiwei Wang, Guangzhi Zhang, Jordan Patterson, Carlos Moctezuma‐Velázquez, David J. Kelvin, Gane Ka‐Shu Wong, Andrew L. Mason – 12 July 2018 – Understanding the heterogeneity of dysregulated pathways associated with the development of hepatocellular carcinoma (HCC) may provide prognostic and therapeutic avenues for disease management.
Devika Kapuria, Varun K. Takyar, Ohad Etzion, Pallavi Surana, James H. O'Keefe, Christopher Koh – 6 July 2018 – Nonalcoholic fatty liver disease (NAFLD) is becoming common in the United States and throughout the world and can progress to cirrhosis, hepatocellular carcinoma, and death. There is a strong association between coronary artery disease and NAFLD due to common risk factors, such as metabolic syndrome, obesity, and diabetes mellitus.
5 July 2018
Nicholas Russo, Robert S. Brown, Nicole T. Shen, Joseph F. Pisa, Saurabh Mukewar, Zaid H. Tafesh, Russell Rosenblatt, Robert E. Schwartz, Vikas Gupta, Aleksey Novikov, Shirley Cohen‐Mekelburg – 5 July 2018
5 July 2018
5 July 2018
Nicholas Russo, Robert S. Brown, Nicole T. Shen, Joseph F. Pisa, Saurabh Mukewar, Zaid H. Tafesh, Russell Rosenblatt, Robert E. Schwartz, Vikas Gupta, Aleksey Novikov, Shirley Cohen‐Mekelburg – 5 July 2018
5 July 2018
5 July 2018